Home
|
Stock Information
|
Contact Us
Technology
Unique Platform
Treatment & Cure
What is RNAi?
Synthetic vs Expressed RNAi
Bibliography
Glossary
|
Intellectual Property
ddRNAi
Patent Estate
IP Actions
|
Pipeline & Partners
Pipeline Summary
In-house Programs
Out-licensed Programs
Licensing
Partners
|
Corporate
Overview
Management
Board
Investigators
Policies
|
Investors
Investor Information
2012 AGM
Annual Reports
Governance
ASX Stock Info
|
News
Media Releases
ASX Releases
Archived Releases
Events
|
Resources
Subscribe
Subscribe for Updates
Please fill in just a few details.
* denotes a required field.
First Name *
Last Name *
Company *
Email *
“Present shRNA expression systems provide good target knockdown and have not generally resulted in unexpected toxicities.”
Snove & Rossi
Nature Methods 2006
Read the paper
